| Raquelle Batya Pfeifer, MS, CCC-SLP | |
|
386 Route 59, Suite 102, Airmont, NY 10952-3428 | |
| (845) 368-7927 | |
| Not Available |
| Full Name | Raquelle Batya Pfeifer |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 386 Route 59, Airmont, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467698357 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 016468 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Raquelle Batya Pfeifer, MS, CCC-SLP 386 Route 59, Suite 102, Airmont, NY 10952-3428 Ph: (845) 368-7927 | Raquelle Batya Pfeifer, MS, CCC-SLP 386 Route 59, Suite 102, Airmont, NY 10952-3428 Ph: (845) 368-7927 |
News Archive
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
As a part of a research collaboration, scientists at the Sahlgrenska Academy at Gotenborg University, Sweden, have developed a new drug candidate against HIV-infection. The new substance, named alphaHGA, will be tested on patients this year.
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings, according to a study presented October 19, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Boys with the sexual birth defects known as hypospadias and cryptorchidism are at risk for developing testicular germ cell cancer, but their relatives are not, according to a new study published online December 21 in the Journal of the National Cancer Institute.
› Verified 1 days ago
Avital Shadovitz, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 386 Route 59, Airmont, NY 10952 Phone: 845-368-7927 | |
Shimon Neuman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7 Murray Dr, Airmont, NY 10952 Phone: 845-659-8606 Fax: 845-782-5849 | |
Mrs. Pesyl Miriam Berman, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Route 59, Suite 102, Airmont, NY 10952 Phone: 845-368-7927 | |
Kerri Donahue, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Margo Ct, Airmont, NY 10901 Phone: 845-300-7775 | |
Judi Dobner Speech Therapy Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Route 59 Ste 102, Airmont, NY 10952 Phone: 845-368-7927 Fax: 845-388-7929 | |
Mrs. Yisha Schwartz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Route 59, Suite 102, Airmont, NY 10952 Phone: 845-368-7927 | |
Mrs. Randy C Dorfman, M.A. CCC-SLP, BRS-FD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 Algonquin Cir, Airmont, NY 10952 Phone: 845-426-6595 Fax: 845-578-1502 |